22nd Century Group Inc (XXII)

[gilbe]

Thanks for the recap Time2Shine, much appreciated!

The initial results from the 800 patient trial appear to be very exciting for XXII. I expect the results of this trial will be included in their Brand A application and will be very influential.

A summary of this trial was presented at the Society for Research on Nicotine and Tobacco Annual meeting in February. Link: http://srnt.org/SRNT_2015_Abstracts_WEB.pdf

See SYM14C on page 25. I included a couple quotes taken from the abstract...

"Together, these data points provide strong evidence consistent with previous smaller trials that significant reductions in nicotine content are likely to reduce smoking and nicotine exposure amongst current users."

"JUSTIFICATION: This study represents the largest clinical trial to date of a potential policy to reduce nicotine content in cigarettes."